Processa Pharmaceuticals Valuation
| PCSA Stock | USD 3.13 0.13 3.99% |
At this time, the company appears to be fairly valued. Processa Pharmaceuticals holds a recent Real Value of $3.0 per share. The prevailing price of the company is $3.13. Our model determines the value of Processa Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -2.71, shares outstanding of 2.27 M, and Shares Owned By Institutions of 7.81 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Processa Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Processa Pharmaceuticals is based on 3 months time horizon. Increasing Processa Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Processa Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Processa Stock. However, Processa Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.13 | Real 3.0 | Hype 3.13 | Naive 3.57 |
The real value of Processa Stock, also known as its intrinsic value, is the underlying worth of Processa Pharmaceuticals Company, which is reflected in its stock price. It is based on Processa Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Processa Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Processa Pharmaceuticals helps investors to forecast how Processa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Processa Pharmaceuticals more accurately as focusing exclusively on Processa Pharmaceuticals' fundamentals will not take into account other important factors: About Processa Pharmaceuticals Valuation
The stock valuation mechanism determines Processa Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Processa Pharmaceuticals. We calculate exposure to Processa Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Processa Pharmaceuticals's related companies.Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. The company was incorporated in 2011 and is based in Hanover, Maryland. Processa Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |